Key facts
- Byonyks Medical Devices’s last known valuation is $125.0M (May 2025).
- It has raised $21.8M across 1 recorded rounds; the latest was Seed Round ($3.5M) in May 2025.
- Notable investors include Ignite - National Technology Fund, Mentors Fund.
- Byonyks Medical Devices has filed 1 Form D with the SEC, most recently Jan 2023 ($1.0M sold to 3 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Byonyks Medical Devices
Funding rounds
1 roundsAbout Byonyks Medical Devices
Developer of home-based peritoneal dialysis devices designed to enhance dialysis therapy for individuals with kidney disease. The company offers next-generation PD platforms that simplify treatment routines and improve patient autonomy, enabling patients seeking flexible at-home dialysis care to better manage their health and daily lives.
- Sector
- Healthcare
- HQ
- Itasca, IL, United States
- Founded
- 2019
- Employees
- 150
- Website
- byonyks.com/
- Ownership
- Privately Held (backing)
Byonyks Medical Devices doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Byonyks Medical Devices shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Byonyks Medical Devices in its N-PORT filings yet. We sweep new filings monthly.